Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

NCT02326857 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02326857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
December 23, 2014
Completion date
September 23, 2020
Enrollment
1,334 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer